Copyright Reports & Markets. All rights reserved.

Global Small Molecule Innovator CDMO Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Small Molecule Innovator CDMO Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Oral Solid Dosage Form
    • 1.3.3 Semi-solid Dosage Form
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Small Molecule Innovator CDMO Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pharmaceutical and Biotech Companies
    • 1.4.3 Academic and Research Institutions
    • 1.4.4 Others
  • 1.5 Global Small Molecule Innovator CDMO Market Size & Forecast
    • 1.5.1 Global Small Molecule Innovator CDMO Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Small Molecule Innovator CDMO Sales Quantity (2020-2031)
    • 1.5.3 Global Small Molecule Innovator CDMO Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Lonza Group
    • 2.1.1 Lonza Group Details
    • 2.1.2 Lonza Group Major Business
    • 2.1.3 Lonza Group Small Molecule Innovator CDMO Product and Services
    • 2.1.4 Lonza Group Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Lonza Group Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Small Molecule Innovator CDMO Product and Services
    • 2.2.4 Thermo Fisher Scientific Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 Cambrex Corporation
    • 2.3.1 Cambrex Corporation Details
    • 2.3.2 Cambrex Corporation Major Business
    • 2.3.3 Cambrex Corporation Small Molecule Innovator CDMO Product and Services
    • 2.3.4 Cambrex Corporation Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Cambrex Corporation Recent Developments/Updates
  • 2.4 CATALENT
    • 2.4.1 CATALENT Details
    • 2.4.2 CATALENT Major Business
    • 2.4.3 CATALENT Small Molecule Innovator CDMO Product and Services
    • 2.4.4 CATALENT Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 CATALENT Recent Developments/Updates
  • 2.5 Siegfried Holding AG
    • 2.5.1 Siegfried Holding AG Details
    • 2.5.2 Siegfried Holding AG Major Business
    • 2.5.3 Siegfried Holding AG Small Molecule Innovator CDMO Product and Services
    • 2.5.4 Siegfried Holding AG Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Siegfried Holding AG Recent Developments/Updates
  • 2.6 Recipharm AB
    • 2.6.1 Recipharm AB Details
    • 2.6.2 Recipharm AB Major Business
    • 2.6.3 Recipharm AB Small Molecule Innovator CDMO Product and Services
    • 2.6.4 Recipharm AB Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Recipharm AB Recent Developments/Updates
  • 2.7 CordenPharma International
    • 2.7.1 CordenPharma International Details
    • 2.7.2 CordenPharma International Major Business
    • 2.7.3 CordenPharma International Small Molecule Innovator CDMO Product and Services
    • 2.7.4 CordenPharma International Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 CordenPharma International Recent Developments/Updates
  • 2.8 Boehringer Ingelheim
    • 2.8.1 Boehringer Ingelheim Details
    • 2.8.2 Boehringer Ingelheim Major Business
    • 2.8.3 Boehringer Ingelheim Small Molecule Innovator CDMO Product and Services
    • 2.8.4 Boehringer Ingelheim Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.9 Piramal Pharma Solutions
    • 2.9.1 Piramal Pharma Solutions Details
    • 2.9.2 Piramal Pharma Solutions Major Business
    • 2.9.3 Piramal Pharma Solutions Small Molecule Innovator CDMO Product and Services
    • 2.9.4 Piramal Pharma Solutions Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Piramal Pharma Solutions Recent Developments/Updates
  • 2.10 Covance
    • 2.10.1 Covance Details
    • 2.10.2 Covance Major Business
    • 2.10.3 Covance Small Molecule Innovator CDMO Product and Services
    • 2.10.4 Covance Small Molecule Innovator CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Covance Recent Developments/Updates

3 Competitive Environment: Small Molecule Innovator CDMO by Manufacturer

  • 3.1 Global Small Molecule Innovator CDMO Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Small Molecule Innovator CDMO Revenue by Manufacturer (2020-2025)
  • 3.3 Global Small Molecule Innovator CDMO Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Small Molecule Innovator CDMO by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Small Molecule Innovator CDMO Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Small Molecule Innovator CDMO Manufacturer Market Share in 2024
  • 3.5 Small Molecule Innovator CDMO Market: Overall Company Footprint Analysis
    • 3.5.1 Small Molecule Innovator CDMO Market: Region Footprint
    • 3.5.2 Small Molecule Innovator CDMO Market: Company Product Type Footprint
    • 3.5.3 Small Molecule Innovator CDMO Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Small Molecule Innovator CDMO Market Size by Region
    • 4.1.1 Global Small Molecule Innovator CDMO Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Small Molecule Innovator CDMO Consumption Value by Region (2020-2031)
    • 4.1.3 Global Small Molecule Innovator CDMO Average Price by Region (2020-2031)
  • 4.2 North America Small Molecule Innovator CDMO Consumption Value (2020-2031)
  • 4.3 Europe Small Molecule Innovator CDMO Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Small Molecule Innovator CDMO Consumption Value (2020-2031)
  • 4.5 South America Small Molecule Innovator CDMO Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Small Molecule Innovator CDMO Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Small Molecule Innovator CDMO Sales Quantity by Type (2020-2031)
  • 5.2 Global Small Molecule Innovator CDMO Consumption Value by Type (2020-2031)
  • 5.3 Global Small Molecule Innovator CDMO Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Small Molecule Innovator CDMO Sales Quantity by Application (2020-2031)
  • 6.2 Global Small Molecule Innovator CDMO Consumption Value by Application (2020-2031)
  • 6.3 Global Small Molecule Innovator CDMO Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Small Molecule Innovator CDMO Sales Quantity by Type (2020-2031)
  • 7.2 North America Small Molecule Innovator CDMO Sales Quantity by Application (2020-2031)
  • 7.3 North America Small Molecule Innovator CDMO Market Size by Country
    • 7.3.1 North America Small Molecule Innovator CDMO Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Small Molecule Innovator CDMO Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Small Molecule Innovator CDMO Sales Quantity by Type (2020-2031)
  • 8.2 Europe Small Molecule Innovator CDMO Sales Quantity by Application (2020-2031)
  • 8.3 Europe Small Molecule Innovator CDMO Market Size by Country
    • 8.3.1 Europe Small Molecule Innovator CDMO Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Small Molecule Innovator CDMO Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Small Molecule Innovator CDMO Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Small Molecule Innovator CDMO Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Small Molecule Innovator CDMO Market Size by Region
    • 9.3.1 Asia-Pacific Small Molecule Innovator CDMO Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Small Molecule Innovator CDMO Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Small Molecule Innovator CDMO Sales Quantity by Type (2020-2031)
  • 10.2 South America Small Molecule Innovator CDMO Sales Quantity by Application (2020-2031)
  • 10.3 South America Small Molecule Innovator CDMO Market Size by Country
    • 10.3.1 South America Small Molecule Innovator CDMO Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Small Molecule Innovator CDMO Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Small Molecule Innovator CDMO Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Small Molecule Innovator CDMO Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Small Molecule Innovator CDMO Market Size by Country
    • 11.3.1 Middle East & Africa Small Molecule Innovator CDMO Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Small Molecule Innovator CDMO Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Small Molecule Innovator CDMO Market Drivers
  • 12.2 Small Molecule Innovator CDMO Market Restraints
  • 12.3 Small Molecule Innovator CDMO Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Small Molecule Innovator CDMO and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Small Molecule Innovator CDMO
  • 13.3 Small Molecule Innovator CDMO Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Small Molecule Innovator CDMO Typical Distributors
  • 14.3 Small Molecule Innovator CDMO Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Small Molecule Innovator CDMO market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Small Molecule Innovator CDMO market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Small Molecule Innovator CDMO market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Small Molecule Innovator CDMO market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Small Molecule Innovator CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Small Molecule Innovator CDMO market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Small Molecule Innovator CDMO
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Small Molecule Innovator CDMO market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Cambrex Corporation, CATALENT, Siegfried Holding AG, Recipharm AB, CordenPharma International, Boehringer Ingelheim, Piramal Pharma Solutions, Covance, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Small Molecule Innovator CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral Solid Dosage Form
    Semi-solid Dosage Form
    Market segment by Application
    Pharmaceutical and Biotech Companies
    Academic and Research Institutions
    Others
    Major players covered
    Lonza Group
    Thermo Fisher Scientific
    Cambrex Corporation
    CATALENT
    Siegfried Holding AG
    Recipharm AB
    CordenPharma International
    Boehringer Ingelheim
    Piramal Pharma Solutions
    Covance
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Small Molecule Innovator CDMO product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Small Molecule Innovator CDMO, with price, sales quantity, revenue, and global market share of Small Molecule Innovator CDMO from 2020 to 2025.
    Chapter 3, the Small Molecule Innovator CDMO competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Small Molecule Innovator CDMO breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Small Molecule Innovator CDMO market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Small Molecule Innovator CDMO.
    Chapter 14 and 15, to describe Small Molecule Innovator CDMO sales channel, distributors, customers, research findings and conclusion.

    Buy now